Nothing Special   »   [go: up one dir, main page]

WO2010040671A2 - Shampooing anti-pelliculaire prévenant la reformation des pellicules - Google Patents

Shampooing anti-pelliculaire prévenant la reformation des pellicules Download PDF

Info

Publication number
WO2010040671A2
WO2010040671A2 PCT/EP2009/062691 EP2009062691W WO2010040671A2 WO 2010040671 A2 WO2010040671 A2 WO 2010040671A2 EP 2009062691 W EP2009062691 W EP 2009062691W WO 2010040671 A2 WO2010040671 A2 WO 2010040671A2
Authority
WO
WIPO (PCT)
Prior art keywords
dandruff
hair
cationic
agent according
acid
Prior art date
Application number
PCT/EP2009/062691
Other languages
German (de)
English (en)
Other versions
WO2010040671A3 (fr
Inventor
Thomas Hippe
Thomas Schröder
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP09736169A priority Critical patent/EP2331211A2/fr
Publication of WO2010040671A2 publication Critical patent/WO2010040671A2/fr
Publication of WO2010040671A3 publication Critical patent/WO2010040671A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic

Definitions

  • the invention relates to a cosmetic agent for controlling dandruff on the basis of a special combination of active ingredients, a method for the treatment of dander by using the agent and the use of the agent for the prophylaxis, reduction, elimination and alleviation of dandruff on hairy body surfaces and to reduce the relapse Dandruff on hairy elaboratereg ions after discontinuation of the agent.
  • Skin and hair cleansers such as those commercially available as liquid soaps, shampoos, shower baths, bubble baths, shower gels, and wash gels, not only must have good detergency, but should also be well tolerated by the skin and hair if used frequently, do not cause excessive defatting or dryness.
  • skin and hair cleaners based on anionic, nonionic and / or amphoteric surfactants, but most preferably based on anionic surfactants are formulated. While such compositions have good detergency, their associated cosmetic properties are inadequate, especially due to the removal of skin and hair lipids and proteins from the skin or hair surface.
  • dandruff Another important aspect of hair cleansing and care is the fight against dandruff, because even the slight appearance of dandruff on the scalp or other hairy body regions is considered a sign of lack of care.
  • dandruff is usually accompanied by itching, which is perceived as disturbing. Itching, on the other hand, causes scratching reactions, which can lead to injuries of the affected skin, which in turn can form the basis for infections and pathogenic agents.
  • anti-dandruff treatment is understood to mean the control of the phytosporum ovale yeast fungus which, in the case of excessive occurrence, is the cause of cosmetic dandruff.
  • the solid zinc pyrithione As an effective anti-dandruff agent, the solid zinc pyrithione has been proven, but must be stabilized, for example, in a Shampoomatrix, since it is there in solid, undissolved form. Without adequate stabilization, the active ingredient would otherwise sink to the bottom and thus lose the shampoo's anti-dandruff action.
  • the dandruff control should be sustainable. Sustainability in this context means that even after discontinuation of the anti-dandruff agent Dysregulation is greatly delayed and / or reduced. Ideally, none should
  • Acrylate polymers (Carbopol types) or xanthan gum gellants.
  • Foaming of a surfactant-containing detergent can affect. They are therefore less suitable for the stabilization of ZnPy (zinc pyrithione) in a hair shampoo, in which an effective foaming is just being sought.
  • the invention therefore antidandruff agents, as the active ingredient combination
  • agents according to the invention solve the aforementioned objects in a particular pH range particularly well. Therefore, agents according to the invention are preferred which have a pH ⁇ 6, preferably ⁇ 5.8 and in particular ⁇ 5.5.
  • compositions according to the invention consequently have a pH of at least 2.5, preferably of at least 3 and in particular of at least 3.5.
  • the compositions according to the invention for achieving effective and gentle cleaning of the hair and hairy body surfaces contain at least one anionic surfactant.
  • anionic surfactants A) which are suitable according to the invention are the alkali metal ammonium and / or di- and triethanolamine salts of 2- or 3-tuply ethoxylated, branched or straight-chain lauryl, pareth and / or trideceth sulfates such as laureth (2) sulfate, laureth (3) sulfates, trideceth (2) sulfates and trideceth (3) sulfates.
  • anionic surfactants are, for example, sodium lauryl ether sulfate (2EO), sodium lauryl ether sulfate (3EO), ammonium lauryl ether sulfate (2EO), ammonium lauryl ether sulfate (3EO), sodium lauryl sulfate, ammonium lauryl sulfate, sodium trideceth sulfate (2EO), sodium trideceth sulfate (3EO), ammonium trideceth sulfate (2EO) and ammonium trideceth sulfate (3EO ).
  • the one or more specific anionic surfactant (s) is (are) in the inventive compositions - based on their total weight - preferably in amounts of from 3 to 20 wt .-%, preferably from 4 to 15 wt .-% and in particular in amounts of 5 to 13 wt .-% used.
  • compositions according to the invention In order to achieve an optimal balance in terms of purification, mildness and foam quality of the compositions according to the invention, it has proven to be particularly preferred if, in addition to the compelling anionic surfactant (s), they comprise at least one further surfactant selected from the group of amphoteric / zwitterionic and / or the nonionic surfactants is selected. Particular preference is given to a ratio of the anionic surfactant A) to the sum of the further surfactants in the range from 6: 1 to 1: 2, preferably from 5: 1 to 1: 1, 5 and in particular in the range from 4.5: 1 to 1: 1, 25.
  • Zwitterionic surfactants which are suitable according to the invention are understood as meaning those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO () or -SO 3 ' " ' group in the molecule
  • Surfactants are the so-called betaines, such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3- Hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarb oxymethylglycinat.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative
  • Amphoteric surfactants according to the invention are understood as meaning those surface-active compounds which, apart from a C 8 -C 24 -alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and which are capable of forming internal salts are.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • amphoteric / zwitterionic surfactants are used in the compositions according to the invention in amounts of from 0.05 to 12.5% by weight, preferably from 0.1 to 10% by weight, more preferably from 0.5 to 7.5% by weight. % and in particular from 1 to 5 wt .-% used - in each case based on the total weight of the composition.
  • suitable nonionic surfactants contain as hydrophilic group z.
  • Such compounds are, for example
  • Polyol fatty acid esters such as the commercially available product ® Hydagen HSP (Cognis) or Sovermol - types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl ester of formula (V) in the R 14 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R 15 is hydrogen or methyl, R 16 is linear or branched alkyl radicals having 1 to 4 carbon atoms and w is a number from 1 to 20 stands, amine oxides,
  • Hydroxy mixed ethers as described, for example, in DE-OS 19738866, sorbitan fatty acid esters and addition products of ethylene oxide onto sorbitan fatty acid esters, for example the polysorbates,
  • the alkyl polyglycosides which can be used according to the invention can only contain one particular alkyl radical R. Usually, however, these compounds are prepared starting from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the particular work-up of these compounds.
  • alkyl polyglycosides in which R consists essentially of C 8 and C 1 alkyl groups or substantially of C 2 - and C 4 - alkyl groups or essentially of C 8 - to C- 6 alkyl groups or consisting essentially of Ci 2 - to Ci 6 - alkyl groups or consisting essentially of Ci 6 to Ci 8 alkyl groups.
  • sugar building block Z it is possible to use any desired mono- or oligosaccharides. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used.
  • Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • alkyl polyglycosides which can be used according to the invention contain on average 1, 1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1: 1 to 1, 8.
  • the alkoxylated homologs of said alkylpolyglycosides can also be used according to the invention. These homologs may contain on average up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.
  • Nonionic surfactants preferred according to the invention are the ethoxylated fatty alcohols and the alkylpolyglycosides which are present in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.05 to 7.5% by weight, based on their total weight. , More preferably from 0.1 to 5 wt .-% and in particular from 0.5 to 3 wt .-% are included.
  • the antidandruff agents according to the invention may further comprise cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines.
  • Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g.
  • alkyltrimethylammonium chlorides dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g.
  • cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the products Armocare ® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats.
  • the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • the cationic surfactants are preferably used in the inventive compositions in amounts of 0.05 to 10 wt .-% based on the entire medium, included. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the second obligatory component of the agent according to the invention is the anti-dandruff agent zinc pyrithione, which must be effectively stabilized in the matrix of the agent, so that no flocculation or no settling of the antidandruff active agent occurs even after prolonged storage of the agent.
  • This stabilization is possible when the ZnPy is combined with a cationic polymer C) in the aforementioned surfactant base.
  • a certain, defined particle size is used.
  • the best stabilization results are achieved if at least 85%, preferably at least 90% and in particular at least 95% of the zinc pyrithione particles have an average particle size ⁇ 1.8 ⁇ m, preferably ⁇ 1.5 ⁇ m, more preferably ⁇ 1, 3 microns and in particular ⁇ 1, 0 microns have.
  • a zinc pyrithione suitable according to the invention is marketed, for example, by the company Connect Chemicals under the trade name "Tomicide ZPT 50.
  • ZnPy is added in an amount in the compositions according to the invention, based on its total weight from 0.01 to 5 wt .-%, preferably from 0.05 to 4 wt .-%, more preferably from 0.1 to 3 wt .-% and in particular from 0.2 to 2 wt .-% used.
  • a suitable compelling component C) according to the invention is cationic
  • Antidandruff composition the rheological properties of the agent (associated with the
  • the cationic polymer causes a conditioning effect on the
  • Cationic galactomannans or their derivatives (C)) which have a cationic charge density of 0.2 to 1.3 meq / g, preferably 0.3 to 1.1 meq / g and in particular 0.4, have proven to be particularly suitable to 0.9 meq / g and a molecular weight of 700,000 to
  • compositions of the invention are in the compositions of the invention - based on their total weight - in an amount of 0.01 to 5 wt .-%, preferably from 0.02 to 4 wt .-%, more preferably from
  • Scalp is an important aspect of the invention. It is therefore advantageous according to the invention if the
  • Anti-dandruff agent in addition to the aforementioned mandatory components in support of the
  • Moisturizing ability of the skin and hair further contains a complex of active ingredients, the D-panthenol and at least one other vitamin, a vitamin precursor or a
  • Vitamin derivative or at least one protein hydrolyzate.
  • D-panthenol is in the compositions of the invention - based on her
  • panthenol The ratio of panthenol to vitamin (vitamin precursor or derivative) or to
  • Protein hydrolyzate is preferably in the range from 50: 1 to 1:20, preferably from 30: 1 to 1:10, more preferably from 25: 1 to 1: 5 and in particular from 20: 1 to 1: 3.
  • Derivatives are to be understood as those representatives which are usually assigned to the groups A, B, C, E, F and H.
  • vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • a component according to the invention for example, vitamin A acid and its esters,
  • Vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate in Consideration preferably contain the vitamin A component in
  • the vitamin B group or the vitamin B complex include u. a.
  • Vitamin B 1 (thiamine)
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 Under this designation are often the compounds nicotinic acid and
  • Nicotinic acid amide (niacinamide).
  • Preferred according to the invention is the nicotinic acid amide, which is preferably present in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal.
  • the said compounds of the vitamin B group are preferably contained in the agents according to the invention in amounts of 0.01-2% by weight, based on the total agent. Amounts of 0.03 - 1 wt .-% are particularly preferred.
  • Vitamin C (ascorbic acid). Vitamin C is used in the compositions according to the invention preferably in amounts of 0.01 to 3 wt .-%, based on the total agent.
  • palmitic acid ester glucosides or phosphates
  • glucosides or phosphates may be preferred.
  • the use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents used according to the invention in amounts of 0.01-1% by weight, based on the total agent ,
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-cf] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is contained in the agents used according to the invention preferably in amounts of 0.0001 to 1, 0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%.
  • the agents according to the invention contain vitamins, provitamins and vitamin precursors from groups A, B, E and H.
  • vitamins and others include vitamins and others.
  • Vitamin precursors may be included at the same time.
  • Protein hydrolyzates in the context of the invention are understood as meaning protein hydrolysates and / or amino acids and their derivatives (H). Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins). The term protein hydrolyzates according to the invention also Totalhydrolysate and individual
  • the invention consists of amino acids and amino acid derivatives
  • Further examples of compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-
  • Methionine-S-Methylsulfoniumchlorid amino acids and their derivatives such as ß-alanine, anthranilic acid or hippuric acid can be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention lies between
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois ® (Interorgana)
  • Lexein ® Inolex
  • kerasol tm ® (Croda) sold.
  • Preferred according to the invention are the protein hydrolysates of plant origin, eg. Eg soybean,
  • Crotein ® (Croda) available.
  • the protein hydrolysates or their derivatives are preferred in the agents according to the invention.
  • UV filters Preservatives, UV filters, vegetable, animal, mineral and synthetic oils,
  • Thickeners Polymers, humectants, hair structurants, hair care products,
  • Preservatives which are suitable according to the invention are selected from the group formed from benzoic acid, propionic acid, salicylic acid and / or sorbic acid, and from the cosmetically acceptable salts and esters of these acids, from formaldehyde and / or
  • Paraformaldehyde from benzyl alcohol, germall, dowicil, kathon, baypival, methylisothiazolines, quaternary ammonium compounds, alcohols and / or from essential oils such as tea tree oil,
  • compositions according to the invention are the compositions according to the invention - based on their total weight - in an amount of 0.01 to 5 wt .-%, preferably in an amount of 0.05 to 3 wt .-% and in particular in an amount of 0.1 to 2 % By weight added.
  • Very particularly preferred preservatives according to the invention are benzoic acid, salicylic acid and / or a cosmetically acceptable salt or a cosmetically acceptable ester of these acids, benzyl alcohol, dowicil, Kathon, Baypival, methylisothiazolines and mixtures of these substances.
  • Suitable antidandruff agents other than B are added to the compositions according to the invention in an amount of 0.05 to 5 wt.%, Preferably of 0.1 to 3.0 wt.% And in particular of 0.3 to 2, 0 wt .-% added (based on the total agent) and are selected from Piroctone olamine, climbazole, ketoconazole, salicylic acid, sulfur, selenium sulfide, tar preparations, Undecenklaivaten, burdock root extracts, poplar extracts, nettle extracts, walnut shell extracts, birch extracts, willow bark extracts, rosemary extracts and / or arnica extracts.
  • an agent according to the invention may also contain UV filters (I).
  • the UV filters to be used according to the invention are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum is in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC ( ⁇ 280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.
  • the UV filters used according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters. Preference is given to those UV filters whose molar extinction coefficient at the absorption maximum is above 15,000, in particular above 20,000.
  • UV filters which have a cationic group, in particular a quaternary ammonium group.
  • Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid-trimethylammonium chloride (lncroquat ® UV-283) and dodecyl tosylate (Escalol ® HP 610).
  • the teaching of the invention also includes the use of a combination of several UV filters. In the context of this embodiment, the combination of at least one water-insoluble UV filter with at least one UV filter with a cationic group is preferred.
  • the UV filters (I) are usually contained in the agents according to the invention in amounts of 0.1-5% by weight, based on the total agent. Levels of 0.4-2.5 wt .-% are preferred.
  • the effect of the agent according to the invention can be optimized by the addition of vegetable, animal, mineral and synthetic oils. These include fatty acids, fatty alcohols, natural and synthetic waxes, which may be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • the fatty acids used can be linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms.
  • isostearic as the commercial products Emersol ® 871 and Emersol ® 875
  • isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linoleic and erucic acid and their technical mixtures, the z.
  • fatty acid cuttings obtainable from coconut oil or palm oil;
  • stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean. In a preferred embodiment, the amount is 0.2-10% by weight, with amounts of 0.5-5% by weight being particularly advantageous.
  • Fatty alcohols which may be used are saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 - C 30 -, preferably C 0 - C 22 - and particularly preferably C 2 - C 22 - carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Isocarb® ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of from 0.1 to 20% by weight, based on the total preparation, preferably in amounts of from 0.1 to 10% by weight.
  • the natural or synthetic waxes used according to the invention are solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the natural and synthetic cosmetic oil bodies which can increase the effect of the agent according to the invention include, for example: liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 ° C Atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether , n-decyl-n-undecyl ether, n-undecyl-n-dodecyl ether and n-hexyl-n-undecyl ether, and di-tert-butyl ether, di-iso-pentyl
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid and their technical mixtures.
  • fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18 alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid-2-ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ® LC)
  • n-butyl stearate oleyl erucate
  • isopropyl palmitate IPP Rilanit ®
  • oleyl Oleate Cetiol ®
  • hexyl laurate Cetiol ® A
  • di-n-butyl adipate Cetiol ® B
  • myrist IPM Rilanit ®
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Mono, - di- and trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol such as Monomuls 90-018 ®, Monomuls 90 L12 ® or Cutina ® MD.
  • the amount used is - based on the total agent - 0.1 to 50 wt.%, Preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.%.
  • Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, thistle oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, rose hip kernel oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil , Marula oil, evening primrose oil, olive oil, palm oil, peach kernel oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.
  • Apricot kernel oil, rosehip kernel oil, jojoba oil, almond oil, olive oil, argan oil, amaranth seed oil, shea butter and cocoa butter are among the natural oil components particularly preferred according to the invention.
  • the vegetable oils are in the inventive compositions - based on the total weight of the agent - in an amount of 0.001 to 10% by weight, preferably from 0.005 to 7 wt .-%, particularly preferably from 0.01 to 5 wt .-% and in particular from 0.05 to 3 wt .-% used.
  • polymers are included in the inventive compositions.
  • polymers are added to the compositions used according to the invention, both cationic, anionic, amphoteric and nonionic polymers having proven effective.
  • Polymers have several functions in the compositions according to the invention.
  • cationic polymers in cosmetic compositions (and the compositions according to the invention can serve as a cosmetic composition) serve as conditioners for the skin and the hair.
  • Cationic polymers also serve as deposition aids for fats, waxes and oils, as well as for silicones.
  • polymers have film-forming properties and often thickening properties, and therefore their use in compositions in which viscosity stability plays a major role is also preferred.
  • cationic polymers which differ from the polymers C). They are added to the compositions of the invention - based on their total weight - in an amount of 0.01 to 5 wt .-%, preferably from 0.02 to 3 and in particular from 0.05 to 2 wt .-%.
  • Cationic polymers which are suitable according to the invention are polymers which have groups in the main and / or side chain which may be “temporary” or “permanent" cationic. According to the invention, “permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group via a CI_ 4 - are attached to a hydrocarbon group made up of acrylic acid, methacrylic acid or derivatives thereof, polymer backbone have been found to be particularly suitable.
  • Homopolymers of the general formula (PI) are particularly suitable.
  • R 18 -H or -CH 3
  • X ' is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (III) and nonionic monomer units, are particularly preferred cationic polymers.
  • R 18 is a methyl group
  • R 19 , R 20 and R 21 are methyl groups m has the value 2.
  • Suitable physiologically tolerated counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions.Holyidene ions, in particular chloride, are particularly suitable.
  • a particularly suitable homopolymer is the, if desired crosslinked, poly If desired, the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol Methylene bisacrylamide is a preferred crosslinking agent
  • the homopolymer is preferably incorporated in the form of
  • Copolymers with monomer units of the formula (PI) contain, as nonionic monomer units, preferably acrylamide, methacrylamide, C 1 -C 4 -alkyl acrylate and C 1 -C 4 -alkyl methacrylates.
  • nonionic monomers is the acrylamide particularly preferred.
  • These copolymers can also be crosslinked, as described above in the case of the homopolymers.
  • a copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • Such copolymers are commercially available under the name Salcare ® SC 92nd Further, particularly preferred cationic polymers are, for example
  • Celquat ® H 100, Celquat L 200 and Polymer JR ® ® 400 are preferred quaternized cellulose derivatives
  • hydrophobically modified cationic polymers as described, for example, in US Pat
  • honey for example the commercial product Honeyquat ® 50,
  • Products Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone), Dow Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicone), SM-2059 (manufacturer: General Electric), SLM 55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th Goldschmidt; di- quaternary polydimethylsiloxanes, quaternium-80).
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially,
  • Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers such as those available under the names Luviquat ® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as those under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and
  • Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.
  • cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers. Also usable according to the invention are the copolymers of vinylpyrrolidone, as they are known as Commercial products Copolymer 845 (manufacturer: ISP), Gaffix ® VC 713 (manufacturer: ISP), Gafquat ® ASCP 1011, Gafquat ® HS 110 Luviquat.RTM ® 8155 and Luviquat.RTM ® MS are available 370th According to the invention particularly preferred, different from c), cationic polymers are those available under the names Celquat ® and Polymer JR ® commercially quaternized cellulose derivatives (Polyquaternium-10 and Polyquaternium-4).
  • cationized protein to the cationic polymers to count wherein the protein hydrolyzate can originate from animal, for example, collagen, milk or keratin, of the plant, for example, from wheat, corn, rice, potatoes, soy or almonds, from marine life forms, such as fish collagen or algae, or biotechnologically derived protein hydrolysates may originate.
  • the protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis.
  • the hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons.
  • Typical examples of the cationic protein hydrolyzates and derivatives according to the invention are the products mentioned under the INCI and called: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein,
  • the cationic protein hydrolysates and derivatives based on plants are also regarded as "hair structureants" and are therefore preferred in the compositions according to the invention in amounts of from 0.001 to 10% by weight, preferably in amounts of from 0.005 to 5% by weight and in particular in amounts of from 0.01 to 3% by weight. % (based on the total weight of funds).
  • the provitamins panthenol and pantolactone, the vitamin derivative niacinamide and the active ingredients arginine, acetyl tyrosine and sericin are among the “hair structuring agents.” Their use is likewise preferred in the compositions according to the invention, which are formulated as cosmetic hair treatment compositions later point of the application described in more detail.
  • compositions according to the invention contain, in addition to the cationic polymers, further natural and / or synthetic polymers which may be anionic or amphoteric and nonionic.
  • the anionic polymers are usually anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid which is available for example under the name Rheothik ® 11-80 is commercially.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene bisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene bisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene bisacrylamide are used.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers.
  • a 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name Stabileze® QM ® commercially available.
  • amphoteric polymers can be used as constituents as polymers for increasing the action of the agent according to the invention.
  • amphoteric polymers includes both those polymers which contain both free amino groups and free COOH or SO 3 H groups in the molecule and are capable of forming internal salts, as well as zwitterionic polymers which contain quaternary ammonium groups and COO in the molecule - or -SO 3 - groups, and those polymers comprising those -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphopolymer suitable is the acrylic resin commercially available as Amphomer ®, which is a copolymer of tert-butylaminoethyl methacrylate, N- (1, 1, 3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group of acrylic acid, Represents methacrylic acid and its simple esters.
  • Amphomer ® is a copolymer of tert-butylaminoethyl methacrylate, N- (1, 1, 3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group of acrylic acid, Represents methacrylic acid and its simple esters.
  • amphoteric polymers are those polymers which are composed essentially
  • Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and
  • Methylhydroxypropylcellulose as for example sold under the trademarks Culminal ® and Benecel ® (AQUALON). shellac
  • Siloxanes These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure.
  • Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups. Glycosidically substituted silicones.
  • the use of the further polymers in amounts of from 0.01 to 10% by weight, based on the total agent, is preferred according to the invention. Amounts of 0.1 to 5 wt .-%, in particular from 0.1 to 3 wt .-%, are particularly preferred.
  • compositions according to the invention may prove advantageous to add in the compositions according to the invention humectants or penetration aids and / or swelling agents (M). These excipients provide better penetration of active ingredients into the keratin fiber or help swell the keratin fiber.
  • urea and urea derivatives include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, lactic acid, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol, for example, propylene glycol monoethyl ether, carbonates, bicarbonates, diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1, 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol.
  • Particularly suitable according to the invention are lactic acid and gly
  • the humectants are in the inventive compositions - based on the total composition - in amounts of 0.01 to 10 wt .-%, preferably in amounts of 0.05 to 5 wt .-% and in particular in amounts of 0.1 to 3 % By weight used.
  • the compositions according to the invention may contain, in addition to the ingredients mentioned above and optional further ingredients, other substances which prevent, alleviate or cure hair loss. In particular, a content of hair root stabilizing active ingredients is advantageous. These substances are described below: Propecia (finasteride) is currently the only preparation that is approved worldwide and has been proven in many studies to be effective and tolerable. Propecia causes less DHT to be produced from testosterone. Minoxidil is probably the oldest proven hair restorer with or without supplemental additives.
  • hair loss For the treatment of hair loss, it may only be used for external application.
  • Minoxidil is only up to 5% share soluble.
  • hair tonic with up to 2% minoxidil content is available without prescription.
  • spironolactone in the form of hair tonic and in combination with minoxidil can be used for external application.
  • Spironolactone acts as an androgen receptor blocker, ie. the binding of DHT to the hair follicles is prevented.
  • hair treatment compositions according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.
  • the agents according to the invention may with particular preference contain one or more amino acids or their physiologically tolerated derivatives, since these substances also serve as "hair structurants", and their use with them in compositions according to the invention, which are formulated as cosmetic hair conditioning agent, is extremely preferred
  • Amino acids or amino acid derivatives which can be used particularly preferably according to the invention are selected from glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine , Histidine, ⁇ -alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4-dihydroxy-L-phen
  • Amino acid (s) / - derivatives preferably from the group glycine and / or alanine and / or VaNn and / or lysine and / or leucine and / or threonine and / or arginine and / or acetyl tyrosine.
  • compositions of the present invention are formulated as a cosmetic hair treatment agent, in the event that they are formulated as a cosmetic hair treatment agent, are the hair care products.
  • Biotin and allantoin but also the plant extracts.
  • these extracts are produced by extraction of the whole plant. However, it may also be preferred in individual cases, the extracts exclusively from flowers and / or
  • Kiwi melon, orange, grapefruit, sage, rosemary, birch, meadowfoam, quenelle,
  • alcohols and mixtures thereof can be used.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and
  • Propylene glycol both as the sole extractant as well as in admixture with water, is preferred. Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and used as solvent in their recovery
  • Extracting agent or extractant mixture Extracting agent or extractant mixture.
  • compositions according to the invention mixtures of several, especially two, different plant extracts.
  • particularly preferred hair cleansers are characterized in that they - based on their weight - 0.001 to 10 wt .-%, in particular 0.01 to 2 wt .-%
  • a silicone may be used as a particularly preferred component of all the compositions of the invention.
  • Silicones can also fulfill various functions in the compositions according to the invention. Thus, on the one hand, they can serve as structurant, but also as skin and hair care agents - their use in the compositions according to the invention is thus also particularly preferred. Silicones are used in the compositions of the invention in amounts of 0.1 to 10 wt .-%, preferably from 0.25 to 5 wt .-% and in particular from 0.5 to 2.5 wt .-%, each based on the total Composition, used.
  • agents according to the invention which comprise at least one silicone selected from:
  • polyalkyl siloxanes polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
  • grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
  • the anti-dandruff preparations according to the invention are preferably a shampoo, a shower bath, a shower gel, a conditioner, a hair conditioner, a hair tonic, a hair gel, a hairspray, a foam, a setting agent, a shaving solution or a deodorant.
  • it is a shampoo.
  • Drug combination can be increased by emulsifiers.
  • emulsifiers are, for example
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls® ® PGPH)
  • Linear and branched fatty acids with 8 to 30 carbon atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • compositions according to the invention may preferably contain at least one nonionic emulsifier having an HLB value of 8 to 18, according to the methods described in the Römpp-Lexikon Chemie (Hrg. J. Falbe, M. Regitz), 10th edition, Georg Thieme Verlag Stuttgart, New York, (1997), page 1764, listed definitions.
  • Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention.
  • Other active ingredients, auxiliaries and additives are, for example
  • Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic,
  • Derivatives such as amylose, amylopectin and dextrins, clays such. As bentonite or fully synthetic hydrocolloids such.
  • hair conditioning compounds such as phospholipids, such as soybean lecithin, egg lecithin and cephalins, and silicone oils,
  • Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol, fiber-structure-improving active ingredients, in particular mono-, di- and oligosaccharides, such as, for example, glucose, galactose, fructose, fructose and lactose,
  • Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
  • Fats and waxes such as spermaceti, beeswax, montan wax and paraffins,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • compositions according to the invention are not subject to any restrictions with regard to their formulation form and can be formulated as emulsion, cream, solution, gel or mousse.
  • a second subject of the invention is the cosmetic use of the anti-dandruff agent according to the invention for the prophylaxis, reduction, elimination and / or alleviation of dandruff on hairy body regions.
  • a third object of the invention is the cosmetic use of the anti-dandruff agent according to the invention for reducing the relapse of dandruff on hairy body regions after discontinuation of the agent.
  • a fourth object of the invention is the cosmetic use of a combination of
  • a fifth object of the invention is a cosmetic method for the prophylaxis, reduction, elimination and / or alleviation of dandruff on hairy body regions, in which an inventive antidandruff agent is applied to the hair or the hairy skin and optionally rinsed again after an exposure time.
  • Zinc pyrithione according to the invention 1, 00 1, 00
  • Plantacare® ® 818UP from 7 to 2.00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un produit cosmétique destiné à la lutte efficace contre les pellicules sur les surfaces pileuses du corps, contenant une combinaison d'agents actifs composée A) de 0,5 à 20 % en poids d'au moins un tensioactif sulfate ou sulfonate anionique, B) de 0,05 à 5 % en poids de zinc-pyrithione de taille particulaire < 2 μm, et C) de 0,05 à 5 % en poids d'un polygalactomannane cationique ou d'un dérivé du polygalactomannane cationique ayant une densité de charge cationique de 0,1 à 1,5 meq/g et un poids moléculaire de 500000 à 3000000. Le traitement des cheveux avec le produit selon l'invention permet également de prévenir la reformation des pellicules après l'arrêt du traitement.
PCT/EP2009/062691 2008-10-08 2009-09-30 Shampooing anti-pelliculaire prévenant la reformation des pellicules WO2010040671A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09736169A EP2331211A2 (fr) 2008-10-08 2009-09-30 Shampooing anti-pelliculaire prévenant la reformation des pellicules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008050430A DE102008050430A1 (de) 2008-10-08 2008-10-08 Anti-Schuppen- und Anti-Rückfall-Shampoo
DE102008050430.0 2008-10-08

Publications (2)

Publication Number Publication Date
WO2010040671A2 true WO2010040671A2 (fr) 2010-04-15
WO2010040671A3 WO2010040671A3 (fr) 2010-07-22

Family

ID=41821119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/062691 WO2010040671A2 (fr) 2008-10-08 2009-09-30 Shampooing anti-pelliculaire prévenant la reformation des pellicules

Country Status (3)

Country Link
EP (1) EP2331211A2 (fr)
DE (1) DE102008050430A1 (fr)
WO (1) WO2010040671A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017097620A1 (fr) * 2015-12-09 2017-06-15 Unilever N.V. Composition de soin capillaire
US20190224103A1 (en) * 2016-10-04 2019-07-25 Rhodia Operations Hair repair composition
CN114072125A (zh) * 2019-07-09 2022-02-18 联合利华知识产权控股有限公司 包含抗头皮屑剂的毛发护理组合物
US11510854B2 (en) * 2017-03-23 2022-11-29 Conopco, Inc. Hair care composition
US11672751B2 (en) 2017-11-17 2023-06-13 Conopco, Inc. Hair care composition

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013025893A1 (fr) * 2011-08-16 2013-02-21 The Gillette Company Compositions de soins personnels comprenant un agent anti-irritation
DE102012219586A1 (de) * 2012-10-25 2014-04-30 Henkel Ag & Co. Kgaa Haarpflegemittel mit ausgewählten Antischuppenwirkstoffen und einem ausgewählten kationischen Keratinhydrolysat
US20150368443A1 (en) * 2014-06-20 2015-12-24 The Procter & Gamble Company Stability of Zinc Pyrithione Dispersions
MX2017013590A (es) 2015-04-23 2018-08-01 Procter & Gamble Administracion de agente anticaspa soluble en surfactante.
BR112018067494B1 (pt) * 2016-03-03 2022-05-10 The Procter & Gamble Company Composição anticaspa em aerossol
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
WO2020005309A1 (fr) 2018-06-29 2020-01-02 The Procter & Gamble Company Composition antipelliculaire en aérosol à faible teneur en tensioactif

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003637A1 (fr) * 1995-07-14 1997-02-06 Unilever Plc Composition de traitement capillaire antimicrobienne
WO2000051718A1 (fr) * 1999-03-05 2000-09-08 Arch Chemicals, Inc. Procede chimique de fabrication de dispersions de particules de pyrithione
WO2003088940A1 (fr) * 2002-04-22 2003-10-30 The Procter & Gamble Company Shampooing contenant un polymere cationique et des particules antipelliculaires
EP1242036B1 (fr) * 1999-12-18 2006-03-08 Cognis IP Management GmbH Utilisation d'agents antipelliculaires nanometriques
WO2006110386A1 (fr) * 2005-04-07 2006-10-19 The Procter & Gamble Company Composition comprenant un materiau particulaire a base de zinc presentant une labilite de zinc relative elevee
WO2008063471A2 (fr) * 2006-11-21 2008-05-29 The Procter & Gamble Company Composition comprenant un matériau de zinc particulaire, une pyrithione ou un sel de métal polyvalent d'une pyrithione et une matrice de gel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
DE4440625A1 (de) 1994-11-14 1996-05-15 Henkel Kgaa Verfahren zur Herstellung hellfarbiger Chitosane
DE19503465A1 (de) 1995-02-03 1996-08-08 Henkel Kgaa Verfahren zur Herstellung von niedrigviskosen kationischen Biopolymeren
DE19738866A1 (de) 1997-09-05 1999-03-11 Henkel Kgaa Schaumarme Tensidmischungen mit Hydroxymischethern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003637A1 (fr) * 1995-07-14 1997-02-06 Unilever Plc Composition de traitement capillaire antimicrobienne
WO2000051718A1 (fr) * 1999-03-05 2000-09-08 Arch Chemicals, Inc. Procede chimique de fabrication de dispersions de particules de pyrithione
EP1242036B1 (fr) * 1999-12-18 2006-03-08 Cognis IP Management GmbH Utilisation d'agents antipelliculaires nanometriques
WO2003088940A1 (fr) * 2002-04-22 2003-10-30 The Procter & Gamble Company Shampooing contenant un polymere cationique et des particules antipelliculaires
WO2006110386A1 (fr) * 2005-04-07 2006-10-19 The Procter & Gamble Company Composition comprenant un materiau particulaire a base de zinc presentant une labilite de zinc relative elevee
WO2008063471A2 (fr) * 2006-11-21 2008-05-29 The Procter & Gamble Company Composition comprenant un matériau de zinc particulaire, une pyrithione ou un sel de métal polyvalent d'une pyrithione et une matrice de gel

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017097620A1 (fr) * 2015-12-09 2017-06-15 Unilever N.V. Composition de soin capillaire
CN108366926A (zh) * 2015-12-09 2018-08-03 荷兰联合利华有限公司 毛发护理组合物
US20180360716A1 (en) * 2015-12-09 2018-12-20 Conopco, Inc., D/B/A Unilever Hair care composition
CN108366926B (zh) * 2015-12-09 2021-03-26 荷兰联合利华有限公司 毛发护理组合物
US11179309B2 (en) * 2015-12-09 2021-11-23 Conopco, Inc. Hair care composition
EA039052B1 (ru) * 2015-12-09 2021-11-26 ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. Композиция для ухода за волосами
US20190224103A1 (en) * 2016-10-04 2019-07-25 Rhodia Operations Hair repair composition
US11510854B2 (en) * 2017-03-23 2022-11-29 Conopco, Inc. Hair care composition
US11672751B2 (en) 2017-11-17 2023-06-13 Conopco, Inc. Hair care composition
CN114072125A (zh) * 2019-07-09 2022-02-18 联合利华知识产权控股有限公司 包含抗头皮屑剂的毛发护理组合物
CN114072125B (zh) * 2019-07-09 2024-03-26 联合利华知识产权控股有限公司 包含抗头皮屑剂的毛发护理组合物

Also Published As

Publication number Publication date
DE102008050430A1 (de) 2010-04-15
WO2010040671A3 (fr) 2010-07-22
EP2331211A2 (fr) 2011-06-15

Similar Documents

Publication Publication Date Title
WO2010040671A2 (fr) Shampooing anti-pelliculaire prévenant la reformation des pellicules
EP2328544B1 (fr) Composition à base de tensioactifs contenant un mélange d&#39;émulsifiants spécial
EP2313072B1 (fr) Composition structurée à propriétés de stabilité au stockage optimales
DE102006037113A1 (de) Mittel zur Bekämfpung von Kopfhautschuppen
DE102009045606A1 (de) Sensitives Haarreinigungsmittel
WO2010015517A2 (fr) Agent de lavage et de soin des cheveux contenant des ingrédients bioactifs
EP2020227B1 (fr) Dérivés de cellulose cationiques en cosmétique
EP1977728A2 (fr) Stabilisation de produits comprenant des tensioactifs
EP2248509A2 (fr) Champoings doux pour les cheveux et le cuir chevelu et conditionneur
EP2459164B1 (fr) Nettoyant cosmétique
EP2151489A2 (fr) Composition de nettoyage contenant un terpolymere
DE102016218984A1 (de) &#34;verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz&#34;
DE102016219005A1 (de) Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102009045856A1 (de) Verwendung kationischer Polymere in Haut- und Haarreinigungsmitteln
WO2010139716A2 (fr) Produit cosmétique de nettoyage tensioactif contenant de la gelée royale
DE102005006836A1 (de) Kationische Cellulosederivate in Kosmetika II
EP2440173A2 (fr) Produit nettoyant cosmétique à effet désodorisant
DE102016218989A1 (de) verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102016219009A1 (de) Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102009028443A1 (de) Tensidhaltiges kosmetisches Haarreinigungsmittel mit Pentaclethra Macroloba Seed Oil
DE102016218994A1 (de) Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102016219001A1 (de) verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
EP2238966A2 (fr) Shampooings doux et conditionneur pour le cuir chevelu
DE102009002883A1 (de) Kopfhautschonende und kopfhautberuhigende Shampoons und Conditioner
DE102009045605A1 (de) Versprühbares Haarreinigungsmittel

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2009736169

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09736169

Country of ref document: EP

Kind code of ref document: A2